Evergraf 0.5 mg Tablet is a specialized pharmaceutical formulation designed to prevent organ rejection in transplant patients and to treat various types of cancers, including breast cancer, pancreatic cancer, lung cancer, and kidney cancer. The key active ingredient in Evergraf 0.5 mg Tablet is Everolimus, which belongs to the therapeutic category of immunosuppressants and anticancer agents. This medication works by suppressing the immune system's activity, thereby reducing the likelihood of organ rejection after transplantation. Additionally, Evergraf 0.5 mg Tablet plays a crucial role in managing certain cancers by inhibiting the growth of cancer cells. The composition of Evergraf 0.5 mg Tablet includes Everolimus as its primary component, which is known for its efficacy in both transplant and oncology settings. Patients prescribed Evergraf 0.5 mg Tablet can benefit from its dual action of preventing organ rejection while also targeting malignant cells in specific cancers. The therapeutic advantages of Evergraf 0.5 mg Tablet make it a vital option for individuals undergoing organ transplants or battling specific types of cancer. Understanding the purpose and composition of Evergraf 0.5 mg Tablet is essential for patients and healthcare providers alike, ensuring that the medication is used effectively and safely.
Uses & Benefits
Evergraf 0.5 mg Tablet is primarily used for the prevention of organ rejection in transplant patients.
This formulation is effective in treating breast cancer, providing a targeted approach to managing this condition.
Patients with pancreatic cancer can benefit from the therapeutic effects of Evergraf 0.5 mg Tablet.
Lung cancer treatment is enhanced with the use of Evergraf 0.5 mg Tablet, offering hope to those affected.
Kidney cancer patients may find Evergraf 0.5 mg Tablet beneficial in their treatment regimen.
The immunosuppressive properties of Evergraf 0.5 mg Tablet help maintain organ viability post-transplant.
Evergraf 0.5 mg Tablet aids in controlling tumor growth by inhibiting cell proliferation.
This medication supports overall health by managing complications associated with organ transplants and cancer therapies.
Patients using Evergraf 0.5 mg Tablet may experience improved quality of life due to effective disease management.
Evergraf 0.5 mg Tablet is often part of a comprehensive treatment plan tailored to individual patient needs.
Healthcare providers may recommend Evergraf 0.5 mg Tablet based on specific patient conditions and treatment goals.
The formulation is designed to be taken as part of a long-term treatment strategy for chronic conditions.
How Evergraf 0.5 mg Tablet works
Evergraf 0.5 mg Tablet works by suppressing the immune system's response, which is crucial for preventing organ rejection and managing certain cancers. This mechanism allows for better integration of transplanted organs and inhibits tumor growth effectively.
Evergraf 0.5 mg Tablet contains Everolimus, which inhibits the mTOR pathway, crucial for cell growth and proliferation.
This suppression of the immune response helps prevent the body from rejecting transplanted organs.
In cancer therapy, Evergraf 0.5 mg Tablet targets rapidly dividing cells, slowing down their growth.
The formulation enhances the effectiveness of other cancer treatments when used in combination.
Evergraf 0.5 mg Tablet reduces the risk of complications associated with organ transplants.
By modulating immune responses, this medication helps maintain a balance between effective treatment and minimizing side effects.
How to use Evergraf 0.5 mg Tablet
Evergraf 0.5 mg Tablet should be taken exactly as prescribed by a healthcare professional.
The recommended dosage typically starts at one tablet daily, but adjustments may be made based on individual response.
This medication is usually taken at the same time each day to maintain consistent blood levels.
Patients should swallow the tablet whole with water; do not crush or chew it.
Duration of treatment with Evergraf 0.5 mg Tablet will depend on the specific condition being treated and should be discussed with a doctor.
Regular monitoring through blood tests may be required to assess drug levels and organ function during treatment with Evergraf 0.5 mg Tablet.
Patients should inform their healthcare provider about any other medications they are taking to avoid potential interactions.
Special instructions may include dietary restrictions or additional medications to enhance treatment efficacy.
Lifestyle Advice
Maintain a balanced diet rich in fruits, vegetables, and whole grains while taking Evergraf 0.5 mg Tablet to support overall health.
Avoid high-sugar foods to manage glucose levels effectively during treatment with Evergraf 0.5 mg Tablet.
Engage in regular physical activity as tolerated to enhance well-being and combat fatigue associated with this medication.
Stay hydrated by drinking plenty of water throughout the day while on Evergraf 0.5 mg Tablet.
Avoid smoking and limit alcohol intake to reduce potential side effects while using Evergraf 0.5 mg Tablet.
Schedule regular follow-up appointments with your healthcare provider to monitor your health status during treatment with Evergraf 0.5 mg Tablet.
Side Effects
Side Effects
Common side effects of Evergraf 0.5 mg Tablet include decreased appetite and fatigue.
Patients may experience increased glucose levels in blood while on Evergraf 0.5 mg Tablet.
Pneumonitis and hypercholesterolemia are potential side effects that require monitoring.
Some individuals may notice joint pain or rash as a reaction to this medication.
Serious side effects include signs of infection such as fever or cough; medical attention should be sought immediately.
Patients should be aware of symptoms like breathlessness or swelling, which may indicate pulmonary complications.
Consultation with a healthcare provider is essential if side effects persist or worsen during treatment with Evergraf 0.5 mg Tablet.
Precautions and Warnings
Precautions & Warnings
Evergraf 0.5 mg Tablet should not be used by individuals with known hypersensitivity to Everolimus or any components of the formulation.
Patients with liver problems or uncontrolled diabetes should consult their doctor before starting this medication.
Pregnant or breastfeeding women are advised against using Evergraf 0.5 mg Tablet without medical guidance due to potential risks to the fetus or infant.
Alcohol consumption should be limited while taking Evergraf 0.5 mg Tablet as it may exacerbate side effects.
Driving or operating machinery is not recommended during treatment due to possible fatigue caused by this medication.
Regular check-ups are necessary to monitor kidney and liver function during treatment with Evergraf 0.5 mg Tablet.
Patients should inform their healthcare provider about any existing infections or recent surgeries prior to starting therapy with Evergraf 0.5 mg Tablet.
1. What is Evergraf 0.5 mg Tablet used for?
Evergraf 0.5 mg Tablet is primarily used for preventing organ rejection in transplant patients and treating various cancers such as breast, pancreatic, lung, and kidney cancers.
2. How should I take Evergraf 0.5 mg Tablet?
Evergraf 0.5 mg Tablet should be taken as prescribed by your doctor, usually once daily at the same time each day, swallowed whole with water.
3. What are the common side effects of Evergraf 0.5 mg Tablet?
Common side effects include decreased appetite, fatigue, increased glucose levels, and potential infections; consult your doctor if these persist.
4. Are there any precautions I should take while using Evergraf 0.5 mg Tablet?
Yes, avoid using Evergraf 0.5 mg Tablet if you have liver problems or uncontrolled diabetes, and consult your doctor if pregnant or breastfeeding.
5. Can I drink alcohol while taking Evergraf 0.5 mg Tablet?
It is advisable to limit alcohol consumption while taking Evergraf 0.5 mg Tablet due to potential interactions that may exacerbate side effects.
6. What should I do if I miss a dose of Evergraf 0.5 mg Tablet?
If you miss a dose of Evergraf 0.5 mg Tablet, take it as soon as you remember unless it's almost time for your next dose; do not double up.
7. How does Evergraf 0.5 mg Tablet work?
Evergraf 0.5 mg Tablet works by suppressing the immune system to prevent organ rejection and inhibiting cancer cell growth through its active ingredient, Everolimus.
Directions for Use
Use only as prescribed by your physician.
Storage and Disposal
Please refer to the product label for storage information.
SKU
153619
Country of Manufacture
India
Manufacturer Address
Mankind Pharma Ltd
Return/Buy Back policy
Non-returnable
Prescription Required
Yes
Storage
Please refer to the product label for storage information.
Seller
Kogland Commerce Pvt Ltd (TN)
Evergraf 0.5 mg Tablet is a specialized pharmaceutical formulation designed to prevent organ rejection in transplant patients and to treat various types of cancers, including breast cancer, pancreatic cancer, lung cancer, and kidney cancer. The key active ingredient in Evergraf 0.5 mg Tablet is Everolimus, which belongs to the therapeutic category of immunosuppressants and anticancer agents. This medication works by suppressing the immune system's activity, thereby reducing the likelihood of organ rejection after transplantation. Additionally, Evergraf 0.5 mg Tablet plays a crucial role in managing certain cancers by inhibiting the growth of cancer cells. The composition of Evergraf 0.5 mg Tablet includes Everolimus as its primary component, which is known for its efficacy in both transplant and oncology settings. Patients prescribed Evergraf 0.5 mg Tablet can benefit from its dual action of preventing organ rejection while also targeting malignant cells in specific cancers. The therapeutic advantages of Evergraf 0.5 mg Tablet make it a vital option for individuals undergoing organ transplants or battling specific types of cancer. Understanding the purpose and composition of Evergraf 0.5 mg Tablet is essential for patients and healthcare providers alike, ensuring that the medication is used effectively and safely.
Uses & Benefits
Evergraf 0.5 mg Tablet is primarily used for the prevention of organ rejection in transplant patients.
This formulation is effective in treating breast cancer, providing a targeted approach to managing this condition.
Patients with pancreatic cancer can benefit from the therapeutic effects of Evergraf 0.5 mg Tablet.
Lung cancer treatment is enhanced with the use of Evergraf 0.5 mg Tablet, offering hope to those affected.
Kidney cancer patients may find Evergraf 0.5 mg Tablet beneficial in their treatment regimen.
The immunosuppressive properties of Evergraf 0.5 mg Tablet help maintain organ viability post-transplant.
Evergraf 0.5 mg Tablet aids in controlling tumor growth by inhibiting cell proliferation.
This medication supports overall health by managing complications associated with organ transplants and cancer therapies.
Patients using Evergraf 0.5 mg Tablet may experience improved quality of life due to effective disease management.
Evergraf 0.5 mg Tablet is often part of a comprehensive treatment plan tailored to individual patient needs.
Healthcare providers may recommend Evergraf 0.5 mg Tablet based on specific patient conditions and treatment goals.
The formulation is designed to be taken as part of a long-term treatment strategy for chronic conditions.
How Evergraf 0.5 mg Tablet works
Evergraf 0.5 mg Tablet works by suppressing the immune system's response, which is crucial for preventing organ rejection and managing certain cancers. This mechanism allows for better integration of transplanted organs and inhibits tumor growth effectively.
Evergraf 0.5 mg Tablet contains Everolimus, which inhibits the mTOR pathway, crucial for cell growth and proliferation.
This suppression of the immune response helps prevent the body from rejecting transplanted organs.
In cancer therapy, Evergraf 0.5 mg Tablet targets rapidly dividing cells, slowing down their growth.
The formulation enhances the effectiveness of other cancer treatments when used in combination.
Evergraf 0.5 mg Tablet reduces the risk of complications associated with organ transplants.
By modulating immune responses, this medication helps maintain a balance between effective treatment and minimizing side effects.
How to use Evergraf 0.5 mg Tablet
Evergraf 0.5 mg Tablet should be taken exactly as prescribed by a healthcare professional.
The recommended dosage typically starts at one tablet daily, but adjustments may be made based on individual response.
This medication is usually taken at the same time each day to maintain consistent blood levels.
Patients should swallow the tablet whole with water; do not crush or chew it.
Duration of treatment with Evergraf 0.5 mg Tablet will depend on the specific condition being treated and should be discussed with a doctor.
Regular monitoring through blood tests may be required to assess drug levels and organ function during treatment with Evergraf 0.5 mg Tablet.
Patients should inform their healthcare provider about any other medications they are taking to avoid potential interactions.
Special instructions may include dietary restrictions or additional medications to enhance treatment efficacy.
Lifestyle Advice
Maintain a balanced diet rich in fruits, vegetables, and whole grains while taking Evergraf 0.5 mg Tablet to support overall health.
Avoid high-sugar foods to manage glucose levels effectively during treatment with Evergraf 0.5 mg Tablet.
Engage in regular physical activity as tolerated to enhance well-being and combat fatigue associated with this medication.
Stay hydrated by drinking plenty of water throughout the day while on Evergraf 0.5 mg Tablet.
Avoid smoking and limit alcohol intake to reduce potential side effects while using Evergraf 0.5 mg Tablet.
Schedule regular follow-up appointments with your healthcare provider to monitor your health status during treatment with Evergraf 0.5 mg Tablet.
Side Effects
Side Effects
Common side effects of Evergraf 0.5 mg Tablet include decreased appetite and fatigue.
Patients may experience increased glucose levels in blood while on Evergraf 0.5 mg Tablet.
Pneumonitis and hypercholesterolemia are potential side effects that require monitoring.
Some individuals may notice joint pain or rash as a reaction to this medication.
Serious side effects include signs of infection such as fever or cough; medical attention should be sought immediately.
Patients should be aware of symptoms like breathlessness or swelling, which may indicate pulmonary complications.
Consultation with a healthcare provider is essential if side effects persist or worsen during treatment with Evergraf 0.5 mg Tablet.
Precautions and Warnings
Precautions & Warnings
Evergraf 0.5 mg Tablet should not be used by individuals with known hypersensitivity to Everolimus or any components of the formulation.
Patients with liver problems or uncontrolled diabetes should consult their doctor before starting this medication.
Pregnant or breastfeeding women are advised against using Evergraf 0.5 mg Tablet without medical guidance due to potential risks to the fetus or infant.
Alcohol consumption should be limited while taking Evergraf 0.5 mg Tablet as it may exacerbate side effects.
Driving or operating machinery is not recommended during treatment due to possible fatigue caused by this medication.
Regular check-ups are necessary to monitor kidney and liver function during treatment with Evergraf 0.5 mg Tablet.
Patients should inform their healthcare provider about any existing infections or recent surgeries prior to starting therapy with Evergraf 0.5 mg Tablet.
1. What is Evergraf 0.5 mg Tablet used for?
Evergraf 0.5 mg Tablet is primarily used for preventing organ rejection in transplant patients and treating various cancers such as breast, pancreatic, lung, and kidney cancers.
2. How should I take Evergraf 0.5 mg Tablet?
Evergraf 0.5 mg Tablet should be taken as prescribed by your doctor, usually once daily at the same time each day, swallowed whole with water.
3. What are the common side effects of Evergraf 0.5 mg Tablet?
Common side effects include decreased appetite, fatigue, increased glucose levels, and potential infections; consult your doctor if these persist.
4. Are there any precautions I should take while using Evergraf 0.5 mg Tablet?
Yes, avoid using Evergraf 0.5 mg Tablet if you have liver problems or uncontrolled diabetes, and consult your doctor if pregnant or breastfeeding.
5. Can I drink alcohol while taking Evergraf 0.5 mg Tablet?
It is advisable to limit alcohol consumption while taking Evergraf 0.5 mg Tablet due to potential interactions that may exacerbate side effects.
6. What should I do if I miss a dose of Evergraf 0.5 mg Tablet?
If you miss a dose of Evergraf 0.5 mg Tablet, take it as soon as you remember unless it's almost time for your next dose; do not double up.
7. How does Evergraf 0.5 mg Tablet work?
Evergraf 0.5 mg Tablet works by suppressing the immune system to prevent organ rejection and inhibiting cancer cell growth through its active ingredient, Everolimus.
Directions for Use
Use only as prescribed by your physician.
Storage and Disposal
Please refer to the product label for storage information.
SKU
153619
Country of Manufacture
India
Manufacturer Address
Mankind Pharma Ltd
Return/Buy Back policy
Non-returnable
Prescription Required
Yes
Storage
Please refer to the product label for storage information.
Seller
Kogland Commerce Pvt Ltd (TN)
Door Step Delivery
Quick and Secure
No Hidden Charges
Pay only what's shown
18K Pincodes Served
With Trust & Reliability
Related Products
Customer Reviews
No reviews yet
Be the first to share your thoughts. Honest feedback helps other shoppers and us serve you better.
